Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jessica Polo y La Borda
Observed names:
J Polo y La Borda,
J. Polo Y La Borda,
Jessica Polo Laborda,
Jessica Polo Y La Borda,
Jessica Polo y la Borda
Institutions:
Hospital Universitario Fundación Jiménez Díaz,
Hospital Central de la Defensa Gómez Ulla,
Instituto de Investigación Sanitaria Fundación Jiménez Díaz
Observed institutions:
Hospital Universitario Rey Juan Carlos,
Hospital Universitario Puerta de Hierro Majadahonda,
Hospital Universitario Fundación Jiménez Díaz,
Hospital Central de la Defensa Gómez Ulla,
Instituto de Investigación Sanitaria Fundación Jiménez Díaz,
Universidad Autónoma de Madrid
show all 6
ORCID:
0000-0002-8250-1065
Observed ORCID:
0000-0002-8250-1065
OpenAlex ID:
A5025872332
Clinical and genetic characteristics of ankylosing spondylitis patients with peripheral arthritis at disease onset.
2019
·
Jessica Polo Y La Borda
, Magdalena Szczypiorska
, et al.
·
PubMed
·
23
Use of risk chart algorithms for the identification of psoriatic arthritis patients at high risk for cardiovascular disease: findings derived from the project CARMA cohort after a 7.5-year follow-up period
2024
·
Jessica Polo y La Borda
, Santos Castañeda
, et al.
·
RMD Open
·
10
PDF
Predictive clinical‐genetic model of long‐term non‐response to tumor necrosis factor‐alpha inhibitor therapy in spondyloarthritis
2019
·
Jessica Polo y La Borda
, José Campos
, et al.
·
International Journal of Rheumatic Diseases
·
10
Combined use of QRISK3 and SCORE2 increases identification of ankylosing spondylitis patients at high cardiovascular risk: Results from the CARMA Project cohort after 7.5 years of follow-up
2024
·
Jessica Polo y la Borda
, Santos Castañeda
, et al.
·
Seminars in Arthritis and Rheumatism
·
9
PDF
Artritis séptica por Scedosporium apiospermum de lenta instauración tras infiltración periarticular
2012
·
Antonio Ramos Martínez
, Beatriz Orden Martínez
, et al.
·
Revista Iberoamericana de Micología
·
3
Efficacy of withdrawal or tapering of bDMARDs vs. standard regimen in axial spondyloarthritis patients: systematic review and meta-analysis informing the update of the Spanish Society of Rheumatology Guideline
2025
·
Hye Sang Park
, Petra Díaz del Campo
, et al.
·
Frontiers in Medicine
·
2
PDF
SAT0405 Clinical, biological and genetic factors, predictors of treatment nonresponse to tnf inhibitors (TNFI), in ankylosing spondylitis (AS) and psoriatic arthritis (PSA)
2017
·
J Polo y La Borda
, J Campos
, et al.
·
Annals of the Rheumatic Diseases
·
1
FRI0420 Association of supressor of cytokine signaling -3 (SOCS-3) expression with interleukin-23 receptor (IL-23R) single nucleotide polymorphisms (SNPS) in ankylosing spondylitis (AS)
2017
·
MA Sánchez
, R Villares
, et al.
·
Annals of the Rheumatic Diseases
·
1
PDF
Ab0874 Combined Use of Score2 and Qrisk3 Increases Identification of Ankylosing Spondylitis Patients at High Cardiovascular Risk: Results From the Carma Project Cohort After 7.5 Years of Follow-up
2024
·
J. Polo Y La Borda
, S. Castañeda
, et al.
·
Annals of the Rheumatic Diseases
Show more works
View as search
Works count:
9
Citation count:
59
H-index:
4
I10-index:
3
Year
Topic
Type